Healthy growth in general insurance premiums and Wealth flows helped Aviva (LSE:AV.) outpace the wider market on Friday, as the insurer reaffirmed double-digit Earnings growth guidance for 2026.

Insurers are not usually the stocks that lead a market higher. On Friday 13 November, Aviva (LSE:AV.) did just that. Its shares closed 3.4% higher at 764.80p after a third-quarter trading update showed general insurance premiums up 19% to £11.8bn. The FTSE 100 rose 0.36% the same day to a three-month closing high of 10,902.56, so Aviva's move outstripped the index by a wide margin.

Aviva and Centrica (LSE:CNA) were the standout risers of the session. To understand why investors responded so positively, it helps to look at where the growth came from and what management said about the rest of the year.

Breaking down the 19%

General insurance premiums rose 19% to £11.8bn. Within that, the UK Business grew faster still, with premiums up 28% to £8bn.

For illustration, the UK accounted for roughly two-thirds of the group's general insurance premiums. That leaves about £3.8bn from outside the UK. Because the UK grew faster than the group total, the non-UK premiums must have grown more slowly than 19%, though the facts available do not give a precise figure for those markets.

Premium growth matters because it is the starting point for future earnings in general insurance. Higher premiums can reflect more customers, higher prices per policy, or both. Whether that growth turns into profit depends on how claims develop, which is why insurers' Underwriting discipline is watched as closely as their sales.

Wealth flows, guidance and capital

General insurance was not the only area of strength. Wealth net flows, the money clients placed with Aviva after withdrawals, rose 31% to £10.9bn. Net flows are a useful indicator for wealth businesses because fees are typically linked to the amount of money under management, so sustained inflows can support future revenue.

Aviva guided to operating Earnings Per Share growth of 11% for 2026. It also expects its health business to make an operating profit of around £90m this year and is targeting wealth operating profit of at least £280m by 2027.

The wealth target is worth noting because it stretches beyond the current year. A goal set for 2027 gives investors a benchmark against which to measure progress over the next few updates, and the 31% rise in net flows is the kind of momentum that such a target would appear to rely on.

Group chief executive Amanda Blanc summed up the period simply as another quarter of delivery.

Another figure in the update was the estimated Solvency II surplus of £7.0bn at 30 September. Solvency II is the regulatory regime that sets how much Capital insurers must hold against their risks, and the surplus represents capital held above that requirement. A larger surplus gives a company more room to absorb shocks, invest in growth or return money to shareholders, although how it is used is a decision for management and the board.

Why the market cared, and the rate backdrop

Several things may have come together on Friday. First, the scale of growth was eye-catching: double-digit increases in both premiums and wealth flows. Second, the earnings guidance offered a clear numerical target for the full year. Third, the mood in the market favoured certain sectors. The session saw gains in energy and defensive stocks as the index climbed to its three-month high, with Centrica rising 3.81% to 160.65p.

The contrast with another insurer is instructive. On Monday 16 November, Legal & General (LSE:LGEN) fell after a trading update in which pension risk transfer volumes disappointed. It was 2.2% lower at midday and about 3% lower at the close, although it still expects 2026 core operating earnings per share growth above its 6–9% target range. The divergence shows that investors are discriminating between insurers based on the specific businesses driving their growth.

Interest rates are a significant Factor for insurers. The Bank of England raised Bank Rate by 25 basis points to 4% on 5 November, and markets are pricing about an 80% chance of another increase in December. The UK 10-year gilt Yield reached 5.35% on Monday, its highest since 23 October.

Higher yields can cut both ways for insurers. They can boost the income earned on Investment portfolios, but they can also affect the valuation of Assets and liabilities and influence how investors value financial stocks relative to bonds. This week's economic data, including UK labour market figures today and October Inflation tomorrow, could shift those expectations. September CPI was 3.5%.

The FTSE 100's own path has been mixed since Friday. On Monday, the index gave up its early gains to close 0.19% lower at 10,881.55, ending the run that had carried it to Friday's high. Monday's weakness was led by miners and technology-linked names, with industrial metals stocks down 2.7% as a sector, rather than by financials.

Key dates to watch

  • Tue 17 Nov 2026 – UK labour market statistics
  • Wed 18 Nov 2026 – UK October CPI
  • Wed 18 Nov 2026 – Bank of England Governor Andrew Bailey speaks
  • Thu 26 Nov 2026 – Bank of England Financial Stability Report, relevant to banks and insurers
  • Thu 17 Dec 2026 – Bank of England MPC decision and minutes

The bottom line

Aviva's 3.4% gain on Friday rested on a combination of fast premium growth, particularly in the UK, healthy wealth inflows and a reaffirmed 11% operating earnings per share growth target for 2026. Together with a £7.0bn Solvency II surplus, the update painted a picture of a business growing while maintaining a sizeable capital buffer.

The next tests come from outside the company as much as inside it. Interest Rate expectations, the Bank of England's Financial Stability Report and the broader direction of the FTSE 100 will shape how investors view insurers in the coming weeks, while the conversion of premium growth into underwriting profit remains the key operational question.